We have established a recombinant HIV gene transfer system based on transient expression of the HIV packaging functions and a recombinant vector genome in monkey kidney Cos cells. The recombinant HIV retroviral vector introduced the neoR gene into CD4+ cells with high efficiency, comparable to that achieved with the highest titer amphotropic murine recombinant retrovirus. Vector preparations were devoid of replication competent, infectious HIV. Gene transfer was dependent on CD4 expression, as shown by expression of the CD4 gene in HeLa cells, and could be inhibited by soluble CD4. This specific and efficient gene transfer system may be useful for development of gene therapy for which T cells are the desired targets. (J. Clin. Invest. 1991. 88:1043-1047
Introduction
Much effort has been focused on the development of strategies for insertion ofgenes into somatic cells for treatment ofgenetic diseases, cancer, or acquired immunodeficiency syndrome (1) (2) (3) . Among the factors that limit the feasibility ofsuch strategies is the efficiency with which genes can be transferred and expressed in human cells. Systems for the exploitation of murine retroviruses for gene transfer are the most advanced. Very useful packaging cell lines capable ofgenerating helper-free replication incompetent, recombinant viruses that exhibit a single round of infection and gene integration have been developed (4, 5) . These systems have provided the recombinant viruses used in the first protocols for in vitro gene transfer into human cells that were subsequently returned to the patient (6) .
Murine retroviruses have been classified according to their host range (7) ; ecotropic viruses infect all murine cells and a few rat cell lines, whereas amphotropic viruses have a broad host range including human cells. The specificity is determined by the major envelope protein, gp70, through its interaction with a membrane protein that acts as a receptor to initiate the Address correspondence and reprint requests to Dr. Takashi Shimada, Clinical Hematology Branch, National Heart, Lung, and Blood Institute, Building 10, Room 7C-103, Bethesda, MD 20892.
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In our experiments, we have shown that recombinant HIV can be used for highly efficient gene transfer into CD4' cells.
Methods
Plasmid construction. Recombinant DNA molecules were constructed by standard methods (13) . The basic vectors, LN, LH, and L, are derivatives of the pMfos's plasmid (14) . Each contains the SV40 origin and A.
B. Figure 1 . the synthetic oligonucleotide to recreate the wild-type sequence. The HXN vector consists of a 0.7-kb XhoI-HindIII (-189 to 1082) fragment containing the HIV-LTR, the packaging signal, and a part ofGag coding sequence, a 2.0-kb XhoI-BamHI fragment containing the bacterial neoR gene driven by the thymidine kinase promoter (TK-NeoR) from pMClneo (19) , and a 0.8-kb XhoI-NarI (-189 to 637) fragment containing the HIV-LTR all inserted between the XhoI and BamHI sites of the L vector. CCD4/LH was constructed by inserting the CMV promoter and 1.7-kb EcoRI-BamHI fragment containing the human CD4 gene from pSP65T4. 8 (20) into the LH vector.
Virus production and transduction. Cos cells, HeLa cells, and human T cells (CEM, HPB-ALL, MT-2) were grown as described (21) .
Cos cells (2 X 106 per 10-cm dish) were transfected with 10 sg of the packaging vector and 10 Mg of the HXN plasmid by the CaPO4 coprecipitation method. The transfected Cos cell conditioned culture medium was collected after 48 h and filtered through 0.22-Mm pore size filters.
Human T cells (2 X 106) were incubated with 5 ml ofthe transfected Cos cell media and 6 Mg/ml polybrene. The medium was replaced with fresh medium after 24 h, and 1,000 Mg/ml active G418 was added 48 h after infection. For titering, the infected cells were dispensed into 96-cell culture plates at 1 X 102 cells/0.1 ml G418 containing medium/ well. CD4+ Hela cells (1 X I0 cells in a 60-mm dish) created by prior introduction of the CCD4/LH plasmid, were incubated with 3 ml of the Cos cell medium in the presence of6 Mg/ml polybrene for 24 h. The cells were replated on 10-cm dishes and cultured in the presence of 1,000 ,g/ml active G418 for 2 wk.
Characterization ofthe recombinant virus. For viral RNA analyses, viral particles from 10-ml transfected Cos cell medium were precipitated with 6% polyethylene glycol (8,000) and 0.3 M NaCl. RNA (Fig. 2 B) . CGPE' produced about threefold more p24 than CGPE-(1 and 3), suggesting that the sequence immediately upstream of the gag initiation codon is important for gag gene expression. Cotransfection with the HXN plasmid increased the level of p24 in the supernatants (2 and 4) but particle formation did not appear to depend on the presence of the recombinant HIV genome (Fig.  2 B) .
RNA was extracted from viral particles precipitated with polyethylene glycol, treated with DNaseI, and slot-blotted onto nylon paper (Fig. 2 B) Targeted transduction of CD4' cells. (T4H) expressing CD4 molecules was e, transfection with the CD4 vector (CCD4/ CD4-parental HeLa cells were incubate from Cos cells transfected with CGPE' an selection for G418 resistance for 2 wk. I peared only with T4H cells (Fig. 4 A) . Co inhibited in a dose-dependent manner by: ml soluble CD4 completely blocked the trai A .
Soluble CD4 at this concentration did not A. Ag/ml (2) , and 10 Ag/ml (3) (Fig. 4 B) .
HIV system similar to that which we have independently devel- (Fig. 3 B) . Inactivation reflects the lack of TAT, the transacting protein required for RNA production from the HIV promoter (25) . Selfinactivating Moloney based vectors have been derived by muTransduction specific tation of the 3' LTR in an effort to minimize promoter and/or Lrental HeLa cells (1) enhancer interference that compromises expression of tranIto transfected Cos scriptional units located between the LTRs after proviral inteion of Cos cells were gration (26) (27) (28) . One advantage of the HIV recombinant sys-)n of the transduction wvith the transfected tem for the study of gene regulation may be the natural silencence ofth tg/ml (1) (10) . The first attempt at human gene therapy has involved the introduction of the human adenosine deaminase gene into T-lymphocytes from a patient with severe combined immunodeficiency syndrome (29) . Insertion and expression of anti-tumor cytokines in tumor infiltrating lymphocytes has been proposed as a treatment modality for cancer (6) . The recombinant HIV system that we have developed may be useful for these therapeutic applications.
